How Pharma, Under Attack from All Sides, Keeps Winning in Washington STAT – Nicholas Forko and Lev Facher | Published: 7/16/2019 Even though Washington has stepped up its rhetorical attacks on the industry and focused its policymaking efforts on reining in high drug prices, the pharmaceutical industry’s time-honored lobbying and advocacy strategies have kept both lawmakers and the Trump administration from landing any of their prescription-drug punches. [read post]